Table 1 Baseline demographics and patient characteristics for the subgroup of patients undergoing 24-h ambulatory BP monitoring

From: 24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension

Characteristic

Aml/HCTZ (10/25 mg) (n=76)

Aml/Val (10/320 mg) (n=71)

Val/HCTZ (320/25 mg) (n=69)

Aml/Val/HCTZ 10/320/25 mg (n=67)

Sex, n (%)

 Male

42 (55.3)

40 (56.3)

40 (58.0)

42 (62.7)

Age, mean (s.d.), years

55.5 (8.9)

53.6 (9.3)

53.0 (8.5)

54.1 (9.9)

Age group, n (%)

65 years

16 (21.1)

9 (12.7)

5 (7.2)

10 (14.9)

Race, n (%)

 White

60 (78.9)

54 (76.1)

56 (81.2)

54 (80.6)

 Black

14 (18.4)

12 (16.9)

10 (14.5)

10 (14.9)

 Other

2 (2.6)

5 (7.0)

3 (4.4)

3 (4.5)

Ethnicity, n (%)

 Hispanic/Latino

13 (17.1)

8 (11.3)

13 (18.8)

9 (13.4)

 Non-Hispanic/Latino

63 (82.9)

63 (88.7)

56 (81.2)

58 (86.6)

BMI, mean (s.d.), kg m −2

30.9 (4.7)

30.8 (4.7)

32.0 (5.6)

31.2 (5.2)

Sitting BP, mean (s.d.), mmHg

 SBP

164.6 (13.5)

166.3 (13.5)

164.4 (12.2)

165.6 (13.3)

 DBP

105.5 (4.4)

105.0 (4.4)

104.9 (5.0)

105.4 (3.9)

24-h ambulatory BP, mean (s.d.), mmHg

 SBP

147.3 (13.1)

149.7 (14.2)

146.4 (13.5)

149.6 (13.4)

 DBP

93.4 (9.4)

93.1 (8.1)

92.8 (9.1)

94.4 (10.0)

Severity of baseline systolic HTN, n (%)

 MSSBP 140 and <160 mm Hg

33 (43.4)

26 (36.6)

26 (37.7)

31 (46.3)

 MSSBP 160 and <200 mm Hg

43 (56.6)

45 (63.4)

43 (62.3)

36 (53.7)

 MSSBP 180 and <200 mm Hg

12 (15.8)

15 (12.1)

7 (10.1)

11 (16.4)

Baseline SBP, mean (s.d.), mm Hg

 MSSBP 140 and <160 mm Hg

153.1 (4.1)

152.9 (4.5)

151.6 (4.2)

154.1 (4.4)

 MSSBP 160 and <200 mm Hg

173.4 (11.4)

174.1 (10.4)

172.1 (8.3)

175.5 (9.9)

 MSSBP 180 and <200 mm Hg

189.2 (6.3)

186.9 (6.3)

185.4 (5.1)

187.5 (5.1)

  1. Abbreviations: Aml, amlodipine; BMI, body mass index; BP, blood pressure; DBP, diastolic BP; HCTZ, hydrochlorothiazide; HTN, hypertension; MSSBP, mean sitting SBP; SBP, systolic BP; s.d., standard deviation; Val, valsartan.